AUSTIN, Texas, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that Marc H. Hedrick, M.D., President and Chief Executive Officer, will deliver a presentation at the 5th Targeted Radiopharmaceuticals Summit Europe, being held December 5-7, 2023 in Berlin, Germany.
5th Annual Radiopharmaceuticals Summit Europe
Presentation Title: | Re-186 Radiolabelled NanoLiposomes for Rare Brain and Spinal Cord Tumors |
Date/Time: | Wednesday, December 6, 2023 at 1:00 – 1:30pm CET |
Session: | Taking a Deep Dive into Novel Targets & Their Basics to Understand How They Affect TRP Development |